Guy Klamer

Glycogen synthase kinase−3β inhibitors suppress leukemia cell growth

Emma Song, Patricia Palladinetti, Guy Klamer et al. · Experimental Hematology · 2010 · 39 citations · Full text

Hematological Malignancy, Leukemia Cell Growth, Cell Regulation +4

Small-Molecule Inhibitor of Glycogen Synthase Kinase 3β 6-Bromoindirubin-3-oxime Inhibits Hematopoietic Regeneration in Stem Cell Recipient Mice

Sylvie Shen, Ning Xu, Guy Klamer et al. · Stem Cells and Development · 2014 · 18 citations

Cell Therapy, Lymphocyte Development, Immune Regulation +21

Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia

Alla Dolnikov, Sylvie Shen, Guy Klamer et al. · Experimental Hematology · 2015 · 17 citations

Hematological Malignancy, Antileukemic Potency, Cd19-specific T Cells +8

GSK‐3β inhibition promotes early engraftment of <i>ex vivo‐</i>expanded haematopoietic stem cells

Alla Dolnikov, Ning Xu, Shuang Shen et al. · Cell Proliferation · 2014 · 17 citations · Full text

Identification and Re-consent of Existing Cord Blood Donors for Creation of Induced Pluripotent Stem Cell Lines for Potential Clinical Applications

Keren M. Abberton, Tricia L McDonald, Mary Diviney et al. · Stem Cells Translational Medicine · 2022 · 16 citations · Full text